Skip to content
patentreply.ai
Office Action responsePricingSecurityDocs

US 12,465,635 · Application 17/545,894

US Patent 12,465,635 — assignment history and current owner

Methods Of Treating Inflammatory Arthritis Using Secukinumab

Who owns US Patent 12,465,635?

US12465635 ("Methods Of Treating Inflammatory Arthritis Using Secukinumab") — current assignee: NOVARTIS AG. Status: Active, estimated expiration December 15, 2031. 5 recorded USPTO assignments.

Based on recorded USPTO assignment data, the apparent operating assignee of US Patent 12,465,635 is NOVARTIS AG. Based on the most recent ownership transfer record (recorded 2022-02-14).

Patent title
Methods Of Treating Inflammatory Arthritis Using Secukinumab
Application number
17/545,894
Apparent operating assignee
NOVARTIS AG
Patent status
Active, estimated expiration December 15, 2031
Recorded assignments
5

Recorded assignment history

ExecutedRecordedConveyanceAssignor(s)Assignee(s)Reel/frame
Nov 10, 2010Feb 14, 2022Ownership TransferTHANGAVELU, KARTHINATHANNOVARTIS AG58999/930
Nov 15, 2010Feb 14, 2022Ownership TransferMPOFU, SHEPHARDNOVARTIS AG59100/781
Mar 21, 2011Feb 14, 2022Ownership TransferRICHARDS, HANNONOVARTIS AG58999/640
Aug 23, 2012Feb 14, 2022Ownership TransferMACHACEK, MATTHIASNOVARTIS PHARMA AG59000/770
Sep 4, 2012Feb 14, 2022Ownership TransferNOVARTIS PHARMA AGNOVARTIS AG59000/951

Scrolls sideways on narrow screens

Chain of title

In 2022, THANGAVELU, KARTHINATHAN assigned the patent to NOVARTIS AG. The most recent ownership transfer, recorded in 2022, lists NOVARTIS AG as assignee.

When does this patent expire?Look up another patent

Apparent recorded rights summary — disclaimer

This tool presents recorded assignment data from the USPTO assignment database. It does not constitute a legal opinion on ownership or title. Assignments may exist that have not been recorded. Corrective records, off-record transfers, court orders, and other events may affect actual ownership. Consult a qualified patent attorney for definitive title analysis.

The prosecution record for your AI

Application 17/545,894 · US 12,465,635

Ownership settled? Give your AI the file.

The recorded chain of title is one part of the record. PatentReply compiles the rest of US 12,465,635, from the claims as filed to the last action, for Claude, ChatGPT, Cursor, or another supported AI workspace.

One new public application a month is free. The first compile takes a few minutes.

Connect PatentReplySee the evidence

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Data sourced from public USPTO assignment records. This tool provides informational summaries and should not be relied upon as legal advice or a definitive title opinion. Always verify patent ownership independently, especially where unrecorded transfers, court orders, or other off-record events may apply.

patentreply.ai
How it worksOffice Action responsePricingDocsConnectToolsSecurityPrivacyTermsContact

© 2026 patentreply.ai

PatentReply does not train on your matters. PatentReply is not a law firm and does not practice law; it requires attorney involvement where legal judgment belongs, and you remain the practitioner of record.